CD8A and breast cancer: Silibinin has been shown to increase the number of CD4+ and CD8+ T cells and neutrophils but decrease macrophage and MDSCs cell numbers in 4T1 luciferase-transfected mammary cancer in female BALB/c and CB17-Prkdc Scid/J mice [138].